ライフサイエンスコーパス: gene vector

1 ecreted alkaline phosphatase (SEAP) reporter gene vector.

2 prove transfection efficiencies of synthetic gene vectors.

3 ds on nonautonomous transposable elements as gene vectors.

4 ex DNA and, thus, to potentially function as gene vectors.

5 trinsic tropism for liver, and are efficient gene vectors.

6 nd endoscopic ultrasound-guided injection of gene vectors.

7 sirable inflammatory responses to adenoviral gene vectors.

8 ing factor to transfection by cationic lipid gene vectors.

9 rotects against immune responses directed at gene vectors.

10 infection with avian leukosis virus-derived gene vectors.

11 could be a powerful, novel way of optimizing gene vector activity.

12 AdiNOS or control gene vector (AdLacZ) was delivered to the liver by donor

13 We describe an analytical method (Geneva: Gene Vector Analysis) to relate genes to biological prop

14 s in D. melanogaster and may be an effective gene vector and gene-tagging agent in this species and d

15 the link between limitations to dispersal in gene vectors and SGS is of key interest to biologists an

16 xplanations of complex data sets, identified gene vectors and their corresponding images that disting

17 emodynamics and thus improving oxygen, drug, gene vector, and effector cell delivery to solid tumors.

18 ation of therapeutic agents, growth factors, gene vectors, and cardioactive and vasoactive agents to

19 Non-viral gene vectors are commonly used for gene therapy owing to

20 Single-gene vectors, bicistronic vectors, and multigene vectors

21 We synthesized the 3 components of a gene vector binding complex: (1) A polyallylamine bispho

22 Two-gene vectors can be used to introduce the therapeutic ge

23 tionic liposomes (CLs) are used worldwide as gene vectors (carriers) in nonviral clinical application

24 Reporter luciferase gene vectors containing the human gamma 3 ECS were used

25 problem in the development of novel TR split gene vectors currently being considered for genes too la

26 phosphonate binding can enable site-specific gene vector delivery from metal surfaces.

27 It is concluded that effective gene vector delivery from metallic stent surfaces can be

28 herapy to treat in-stent restenosis by using gene vector delivery from the metallic stent surfaces ha

29 These finding suggest that gene vector delivery of soluble CD8 may have therapeutic

30 from An. gambiae have not been exploited as gene vectors/drivers because none have been isolated.

31 arkov chain whose state space is composed of gene vectors, each state of the Markov chain correspondi

32 The viral gene vectors explored to date cannot selectively transdu

33 or suppressor activity with that of a single gene vector for p53 (Adp53).

34 d out by inserting it into the pGL3 reporter gene vector for transfection into NIH3T3 cells.

35 The development of plant virus gene vectors for expression of foreign genes in plants p

36 -positive cancer cells, would make excellent gene vectors for GDEPT therapy of hepatocellular carcino

37 re effective than is a combination of single gene vectors for p14 and p53.

38 ellular barriers typically prevent non-viral gene vectors from having an effective transfection effic

39 This new gene vector has a great potential in clinical gene thera

40 Incorporation of drug resistance genes into gene vectors has 2 important roles in stem cell gene the

41 addition, the expression from intact globin gene vectors has been variable in red blood cells due to

42 throughout the heart and may be useful as a gene vector in organ transplantation.

43 ation is a prerequisite for the transport of gene vectors in living cells.

44 Hilbert space to decompose the nonidentified gene vector into two components that are correlated and

45 apy with various viral vectors and non-viral gene vectors is well tolerated by patients, and continue

46 se fibroblasts transduced with this ribozyme gene vector library were selected in a focus formation a

47 produced gadolinium/blue dye and gadolinium/gene-vector media by mixing Magnevist with a trypan-blue

48 itive PBN is composed of a pair, the current gene vector occupied by the network and the current cons

49 l protein translation, a luciferase reporter gene vector, pCMV/T7-NCRCdelta-luc, was constructed cont

50 loned into the mammalian luciferase reporter gene vector pGL3-Basic.

51 nto a T-vector constructed from the reporter gene vector pGL3.

52 action and cloned into a luciferase reporter gene vector, pGL3-basic.

53 Many gene vectors require large particle numbers for even ear

54 To engineer gene vectors that target striated muscles after systemic

55 When cloned into reporter gene vectors, the genomic fragment showed significant pr

56 hor considers the plausibility of developing gene vector therapies that use conditional expression sy

57 oretically have many desirable properties as gene vectors, there are several practical barriers to su

58 attributed to the inability of conventional gene vectors to achieve gene transfer throughout highly

59 ed origin could be used practically in human gene vectors to improve their efficiency in therapy and

60 ent, tunable method for sustained release of gene vectors to the vasculature.

61 ute, gene expression, and time course of AAV gene vector transfer to LG.

62 A reporter gene vector was constructed so that expression of an ins

63 f this methodology produced a TBSV DNA-based gene vector which yielded readily detectable levels of l

64 m) protoplast system and a modified reporter gene vector with an internal transformation control, 25

65 thesis of new 3D "Single Cyclized" polymeric gene vectors with well-defined compositions and function